Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway-Reference-Cited by-同舟云学术

Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway

Published:2000-03 Issue:3 Volume:6 Page:283-289
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Tamada Koji,Shimozaki Koji,Chapoval Andrei I.,Zhu Gefeng,Sica Gabriel,Flies Dallas,Boone Tom,Hsu Hailing,Fu Yang-Xin,Nagata Shigekazu,Ni Jian,Chen Lieping

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm0300_283.pdf

Reference33 articles.

1. Schwartz, R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065 –1068 (1992).

2. Cross, A.H. et al. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J. Clin. Invest. 95, 2783–2789 (1995).

3. Lenschow, D.J. et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789– 792 (1992).

4. Blazar, B.R., Taylor, P.A., Linsley, P.S. & Vallera, D.A. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood 83, 3815– 3825 (1994).

5. Chen, L. et al. Costimulation of anti-tumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71, 1093–1102 (1992).

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth;2024-07-30

2. IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment;The Journal of Immunology;2023-07-17

3. Tumor Necrosis Factor Superfamily 14 (LIGHT) Restricts Neovascularization by Decreasing Circulating Endothelial Progenitor Cells and Function;International Journal of Molecular Sciences;2023-04-10

4. LIGHT Amplification by NF-κB Contributes to TLR3 Signaling Pathway-Induced Acute Hepatitis;Mediators of Inflammation;2023-01-09

5. Association between genetic variants and the risk of nivolumab-induced immune-related adverse events;Pharmacogenomics;2022-11